global-supply

Trump faces dilemma as U.S. oil reels from record biofuels targets

By Chris Prentice NEW YORK (Reuters) – The Obama administration signed its final plan for renewable fuel use in the United States last week, leaving an oil industry reeling from the most aggressive biofuel targets yet as President-elect Donald Trump takes over…

Here is the original:
Trump faces dilemma as U.S. oil reels from record biofuels targets

global-supply

Unions, gig-economy firms gear up for New York benefits battle

Faced with a barrage of lawsuits from workers demanding benefits and recognition as employees, some companies in the fast-growing 'gig economy' are looking to settle the issues through legislation. Joseph Morelle, the number two Democrat in the New York State…

Read more from the original source: 
Unions, gig-economy firms gear up for New York benefits battle

global-supply

Oil prices gyrate as OPEC heavyweights head to Vienna

By Libby George LONDON (Reuters) – Oil prices gained more than one percent on Monday in volatile trading after falling as much as 2 percent, recouping the losses as the market reacted to the shaky prospect of major producers being able to agree output cuts at a meeting on Wednesday. U.S. West Texas Intermediate (WTI) crude futures also …

See the original post here:
Oil prices gyrate as OPEC heavyweights head to Vienna

global-supply

Oil edges lower amid scepticism about output freeze

Oil prices inched lower on Wednesday as market participants remained skeptical that producers will reach an agreement to freeze output to rein in a global supply glut. London Brent crude for November delivery was down 4 cents at $47.22 a barrel by 2018 EST,

Here is the original post:
Oil edges lower amid scepticism about output freeze

global-supply

Valeant CEO cuts outlook for ‘distracted’ company, shares plunge

Valeant Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a “distracted organization” with a debt-loaded balance sheet. The maker of toenail fungus cream Jublia and anti-depressant drug Wellbutrin, which has faced intense scrutiny for business and accounting practices, missed first-quarter profit estimates on weakness in its dermatology business.

More:
Valeant CEO cuts outlook for ‘distracted’ company, shares plunge

global-supply

Oil hits 2016 high on U.S. draw forecasts, Nigeria woes

Oil prices jumped more than 1 percent on Tuesday, hitting 2016 highs, with U.S. crude settling above $50 a barrel the first time in almost a year, on expectations of domestic stockpile draws and worries about global supply shortfalls from attacks on Nigeria'

Originally posted here:
Oil hits 2016 high on U.S. draw forecasts, Nigeria woes

global-supply

Apple seeks India government approval to set up retail stores

MUMBAI (Reuters) – Apple Inc has filed an application with the Indian government to set up its retail outlets in one of the fastest-growing smartphone markets, a spokesman for the Cupertino

Read more here:
Apple seeks India government approval to set up retail stores

global-supply

Oil sinks again on glut as U.S. crude hits new lows

Oil futures fell further on Wednesday, with U.S. crude touching its lowest since 2003, as a global supply glut bumped up against bearish financial news that sparked deeper worries over demand. U.S. crude oil dropped more than 4 percent in early trading, falling to as far as $27.32 a barrel. “You need the

See the original post here: 
Oil sinks again on glut as U.S. crude hits new lows

global-supply

Record highs predicted for bitcoin in 2016 as new supply halves

The reason 2016 looks set to be different is that bitcoin's price is likely to be driven in large part by similar factors to a traditional fiat currency, following the age-old principles of supply and demand. Instead of being controlled by a central bank, bitcoin relies on so-called “mining” computers that validate blocks of transactions by competing to solve mathematical

More here: 
Record highs predicted for bitcoin in 2016 as new supply halves

global-supply

Exclusive: Shire closer to deal to buy Baxalta – sources

By Carl O'Donnell and Pamela Barbaglia NEW YORK/LONDON (Reuters) – Drug maker Shire Plc has made a new acquisition offer for peer Baxalta International Inc that is roughly in line with the latter's valuation expectations, making a deal…

View post: 
Exclusive: Shire closer to deal to buy Baxalta – sources

Next Page »